217 related articles for article (PubMed ID: 11956826)
1. Immunohistomorphologic and molecular cytogenetic analysis of a carcinosarcoma of the urinary bladder.
Gronau S; Menz CK; Melzner I; Hautmann R; Möller P; Barth TF
Virchows Arch; 2002 Apr; 440(4):436-40. PubMed ID: 11956826
[TBL] [Abstract][Full Text] [Related]
2. Analysis by comparative genomic hybridization of epithelial and spindle cell components in sarcomatoid carcinoma and carcinosarcoma: histogenetic aspects.
Torenbeek R; Hermsen MA; Meijer GA; Baak JP; Meijer CJ
J Pathol; 1999 Nov; 189(3):338-43. PubMed ID: 10547594
[TBL] [Abstract][Full Text] [Related]
3. Nonrandom chromosomal changes in transitional cell carcinoma of the bladder.
Gibas Z; Prout GR; Connolly JG; Pontes JE; Sandberg AA
Cancer Res; 1984 Mar; 44(3):1257-64. PubMed ID: 6692407
[TBL] [Abstract][Full Text] [Related]
4. Metastasizing vulvar carcinosarcoma with squamous carcinomatous and leiomyosarcomatous differentiation: genetic evidence of clonal origin.
Adam P; Zettl A; Zollner U; Dietl J; Müller-Hermelink HK; Eck M
Hum Pathol; 2005 Oct; 36(10):1143-7. PubMed ID: 16226117
[TBL] [Abstract][Full Text] [Related]
5. Genomic aberrations in carcinomas of the uterine corpus.
Micci F; Teixeira MR; Haugom L; Kristensen G; Abeler VM; Heim S
Genes Chromosomes Cancer; 2004 Jul; 40(3):229-46. PubMed ID: 15139002
[TBL] [Abstract][Full Text] [Related]
6. Histogenesis of sarcomatoid urothelial carcinoma of the urinary bladder: evidence for a common clonal origin with divergent differentiation.
Sung MT; Wang M; MacLennan GT; Eble JN; Tan PH; Lopez-Beltran A; Montironi R; Harris JJ; Kuhar M; Cheng L
J Pathol; 2007 Mar; 211(4):420-30. PubMed ID: 17236170
[TBL] [Abstract][Full Text] [Related]
7. Genomic imbalances in urothelial cancer: intratumor heterogeneity versus multifocality.
Prat E; Del Rey J; Camps J; Ponsa I; Lloreta J; Egozcue J; Gelabert A; Campillo M; Miro R
Diagn Mol Pathol; 2008 Sep; 17(3):134-40. PubMed ID: 18382360
[TBL] [Abstract][Full Text] [Related]
8. Cytogenetic analysis shows that carcinosarcomas of the breast are of monoclonal origin.
Teixeira MR; Qvist H; Bøhler PJ; Pandis N; Heim S
Genes Chromosomes Cancer; 1998 Jun; 22(2):145-51. PubMed ID: 9598802
[TBL] [Abstract][Full Text] [Related]
9. Improved clonality analysis of multifocal bladder tumors by combination of histopathologic organ mapping, loss of heterozygosity, fluorescence in situ hybridization, and p53 analyses.
Denzinger S; Mohren K; Knuechel R; Wild PJ; Burger M; Wieland WF; Hartmann A; Stoehr R
Hum Pathol; 2006 Feb; 37(2):143-51. PubMed ID: 16426913
[TBL] [Abstract][Full Text] [Related]
10. Detection of chromosomal alterations in bladder transitional cell carcinomas from Northern China by comparative genomic hybridization.
Qin SL; Chen XJ; Xu X; Shou JZ; Bi XG; Ji L; Han YL; Cai Y; Wei F; Ma JH; Wu M; Zhan QM; Wang MR
Cancer Lett; 2006 Jul; 238(2):230-9. PubMed ID: 16125302
[TBL] [Abstract][Full Text] [Related]
11. Identical clonality of both components of mammary carcinosarcoma with differential loss of heterozygosity.
Zhuang Z; Lininger RA; Man YG; Albuquerque A; Merino MJ; Tavassoli FA
Mod Pathol; 1997 Apr; 10(4):354-62. PubMed ID: 9110298
[TBL] [Abstract][Full Text] [Related]
12. [Analysis of chromosome copy number changes in leiomyosarcoma through molecular cytogenetic methods].
Otaño-Joos M; Mechtersheimer G; Ohl S; Lehnert T; Willeke F; Möller P; Otto HF; Lichter P; Joos S
Verh Dtsch Ges Pathol; 1998; 82():207-9. PubMed ID: 10095435
[TBL] [Abstract][Full Text] [Related]
13. [A case of true carcinosarcoma in bladder diverticulum].
Hara S; Miyazaki S; Yamazaki T; Hara I; Fujisawa M; Gohji K; Okada H; Arakawa S; Kamidono S; Hanioka K
Hinyokika Kiyo; 1999 Apr; 45(4):265-8. PubMed ID: 10363148
[TBL] [Abstract][Full Text] [Related]
14. Spindle-cell ameloblastic carcinoma: A case report with immunohistochemical, ultrastructural, and comparative genomic hybridization analyses.
Kawauchi S; Hayatsu Y; Takahashi M; Furuya T; Oga A; Niwa S; Sasaki K
Oncol Rep; 2003; 10(1):31-4. PubMed ID: 12469140
[TBL] [Abstract][Full Text] [Related]
15. The genetics of bladder cancer: a cytogeneticist's perspective.
Wolff DJ
Cytogenet Genome Res; 2007; 118(2-4):177-81. PubMed ID: 18000368
[TBL] [Abstract][Full Text] [Related]
16. Assessment by M-FISH of karyotypic complexity and cytogenetic evolution in bladder cancer in vitro.
Ratliff TL
J Urol; 2005 Nov; 174(5):2065. PubMed ID: 16217396
[No Abstract] [Full Text] [Related]
17. [Detection of urothelial carcinoma of the urinary bladder by multicolor fluorescence in situ hybridization].
Zhang YG; Bi XG; Han YL; Cai Y; Xu X; Wu YP; Yang YL; Ma JH; Zhao P; Jia XM; Wang MR
Ai Zheng; 2007 Feb; 26(2):189-93. PubMed ID: 17298751
[TBL] [Abstract][Full Text] [Related]
18. [Chromosomal analysis of primary superficial tumors of the bladder].
Martorana G; Giberti C; de Ferrari M; Ottaggio L; Giuliani L
J Urol (Paris); 1983; 89(7):489-92. PubMed ID: 6655279
[TBL] [Abstract][Full Text] [Related]
19. Novel recurrent structural chromosomal aberrations in primary bladder cancer.
Panani AD; Ferti AD; Raptis SA; Roussos C
Anticancer Res; 2004; 24(5A):2967-74. PubMed ID: 15517903
[TBL] [Abstract][Full Text] [Related]
20. Identification of cytogenetic subgroups and karyotypic pathways in transitional cell carcinoma.
Höglund M; Säll T; Heim S; Mitelman F; Mandahl N; Fadl-Elmula I
Cancer Res; 2001 Nov; 61(22):8241-6. PubMed ID: 11719456
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
